BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25154814)

  • 21. MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3.
    Wu H; Xiao Z; Zhang H; Wang K; Liu W; Hao Q
    Anticancer Drugs; 2014 Aug; 25(7):799-809. PubMed ID: 24686007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
    Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
    Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells].
    Zhou Y; Wang SY; Yang XK; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):97-100. PubMed ID: 21575475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo.
    Zhang LL; Zhang J; Shen L; Xu XM; Yu HG
    Mol Med Rep; 2013 May; 7(5):1387-90. PubMed ID: 23546174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
    Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
    Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell fate regulation by gelsolin in human gynecologic cancers.
    Abedini MR; Wang PW; Huang YF; Cao M; Chou CY; Shieh DB; Tsang BK
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14442-7. PubMed ID: 25246592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Solár P; Sytkowski AJ
    Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S; Choi EJ; Jin C; Kim DH
    Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression.
    Wu YH; Huang YF; Chen CC; Chou CY
    Cell Death Dis; 2019 Apr; 10(4):322. PubMed ID: 30975980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
    Juliachs M; Muñoz C; Moutinho CA; Vidal A; Condom E; Esteller M; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
    Clin Cancer Res; 2014 Feb; 20(3):658-67. PubMed ID: 24277456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation.
    Mansouri A; Zhang Q; Ridgway LD; Tian L; Claret FX
    Oncol Res; 2003; 13(6-10):399-404. PubMed ID: 12725530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer.
    Han CY; Patten DA; Lee SG; Parks RJ; Chan DW; Harper ME; Tsang BK
    Mol Carcinog; 2019 Nov; 58(11):2161-2174. PubMed ID: 31486135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.
    Ali AY; Farrand L; Kim JY; Byun S; Suh JY; Lee HJ; Tsang BK
    Ann N Y Acad Sci; 2012 Oct; 1271(1):58-67. PubMed ID: 23050965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
    Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
    Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
    Yang H; He L; Kruk P; Nicosia SV; Cheng JQ
    Int J Cancer; 2006 Nov; 119(10):2304-12. PubMed ID: 16894566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
    Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
    J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
    Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
    Hahne JC; Honig A; Meyer SR; Gambaryan S; Walter U; Wischhusen J; Häussler SF; Segerer SE; Fujita N; Dietl J; Engel JB
    Oncol Rep; 2012 Dec; 28(6):2023-8. PubMed ID: 22992944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.